54.04 USD
+0.25 (+0.46%)
54.09 USD
+0.05 (+0.09%)
We assign a fundamental rating of 5 out of 10 to MDLZ. MDLZ was compared to 86 industry peers in the Food Products industry. MDLZ has an excellent profitability rating, but there are concerns on its financial health. MDLZ has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year MDLZ was profitable.
In the past year MDLZ had a positive cash flow from operations.
Each year in the past 5 years MDLZ has been profitable.
In the past 5 years MDLZ always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.95%, MDLZ is in the better half of the industry, outperforming 74.42% of the companies in the same industry.
MDLZ has a Return On Equity of 13.49%. This is amongst the best in the industry. MDLZ outperforms 82.56% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.25%, MDLZ is in the better half of the industry, outperforming 68.60% of the companies in the same industry.
MDLZ had an Average Return On Invested Capital over the past 3 years of 7.83%. This is significantly below the industry average of 28.69%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROIC | 6.25% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
1.3 Margins
With an excellent Profit Margin value of 9.38%, MDLZ belongs to the best of the industry, outperforming 86.05% of the companies in the same industry.
In the last couple of years the Profit Margin of MDLZ has declined.
MDLZ has a better Operating Margin (11.59%) than 77.91% of its industry peers.
MDLZ's Operating Margin has improved in the last couple of years.
MDLZ has a better Gross Margin (31.05%) than 72.09% of its industry peers.
MDLZ's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% |
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
MDLZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
MDLZ has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MDLZ has less shares outstanding
The debt/assets ratio for MDLZ has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.22 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
MDLZ has a Altman-Z score (2.22) which is comparable to the rest of the industry.
MDLZ has a debt to FCF ratio of 9.31. This is a negative value and a sign of low solvency as MDLZ would need 9.31 years to pay back of all of its debts.
MDLZ has a better Debt to FCF ratio (9.31) than 63.95% of its industry peers.
MDLZ has a Debt/Equity ratio of 0.76. This is a neutral value indicating MDLZ is somewhat dependend on debt financing.
MDLZ has a Debt to Equity ratio of 0.76. This is in the lower half of the industry: MDLZ underperforms 60.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Altman-Z | 2.22 |
ROIC/WACC0.84
WACC7.44%
2.3 Liquidity
MDLZ has a Current Ratio of 0.61. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
MDLZ has a Current ratio of 0.61. This is amonst the worse of the industry: MDLZ underperforms 88.37% of its industry peers.
MDLZ has a Quick Ratio of 0.61. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
MDLZ's Quick ratio of 0.37 is on the low side compared to the rest of the industry. MDLZ is outperformed by 82.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 |
3. Growth
3.1 Past
The earnings per share for MDLZ have decreased strongly by -21.70% in the last year.
MDLZ shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.91% yearly.
The Revenue has been growing slightly by 4.13% in the past year.
Measured over the past years, MDLZ shows a small growth in Revenue. The Revenue has been growing by 7.09% on average per year.
EPS 1Y (TTM)-21.7%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-26.26%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
3.2 Future
MDLZ is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.92% yearly.
MDLZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.83% yearly.
EPS Next Y-14.28%
EPS Next 2Y-3.35%
EPS Next 3Y0.55%
EPS Next 5Y3.92%
Revenue Next Year4.92%
Revenue Next 2Y4.48%
Revenue Next 3Y4.2%
Revenue Next 5Y3.83%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.96 indicates a rather expensive valuation of MDLZ.
Compared to the rest of the industry, the Price/Earnings ratio of MDLZ is on the same level as its industry peers.
MDLZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.54.
With a Price/Forward Earnings ratio of 16.77, MDLZ is valued correctly.
Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than 66.28% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MDLZ to the average of the S&P500 Index (23.78), we can say MDLZ is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.96 | ||
| Fwd PE | 16.77 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDLZ is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as MDLZ.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.45 | ||
| EV/EBITDA | 15.21 |
4.3 Compensation for Growth
The decent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.74
EPS Next 2Y-3.35%
EPS Next 3Y0.55%
5. Dividend
5.1 Amount
MDLZ has a Yearly Dividend Yield of 3.58%. Purely for dividend investing, there may be better candidates out there.
MDLZ's Dividend Yield is a higher than the industry average which is at 4.99.
Compared to an average S&P500 Dividend Yield of 2.27, MDLZ pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.58% |
5.2 History
On average, the dividend of MDLZ grows each year by 10.52%, which is quite nice.
MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.52%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
MDLZ pays out 69.92% of its income as dividend. This is not a sustainable payout ratio.
The dividend of MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP69.92%
EPS Next 2Y-3.35%
EPS Next 3Y0.55%
54.04
+0.25 (+0.46%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners89.33%
Inst Owner Change3.26%
Ins Owners0.15%
Ins Owner Change-0.01%
Market Cap69.73B
Revenue(TTM)37.65B
Net Income(TTM)3.53B
Analysts78.24
Price Target70.08 (29.68%)
Short Float %2.39%
Short Ratio3.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.58% |
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP69.92%
Div Incr Years11
Div Non Decr Years11
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.9%
Min EPS beat(2)0.24%
Max EPS beat(2)5.55%
EPS beat(4)3
Avg EPS beat(4)3.23%
Min EPS beat(4)-3.07%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.65%
EPS beat(12)11
Avg EPS beat(12)5.57%
EPS beat(16)14
Avg EPS beat(16)5.23%
Revenue beat(2)0
Avg Revenue beat(2)-1.02%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-1.65%
Revenue beat(12)4
Avg Revenue beat(12)-0.26%
Revenue beat(16)7
Avg Revenue beat(16)0.39%
PT rev (1m)-3.72%
PT rev (3m)-6.6%
EPS NQ rev (1m)-1.5%
EPS NQ rev (3m)-14.58%
EPS NY rev (1m)-1.03%
EPS NY rev (3m)-4.15%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-1.36%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-0.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.96 | ||
| Fwd PE | 16.77 | ||
| P/S | 1.85 | ||
| P/FCF | 30.45 | ||
| P/OCF | 19.5 | ||
| P/B | 2.66 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.21 |
EPS(TTM)2.85
EY5.27%
EPS(NY)3.22
Fwd EY5.96%
FCF(TTM)1.77
FCFY3.28%
OCF(TTM)2.77
OCFY5.13%
SpS29.17
BVpS20.29
TBVpS-13.7
PEG (NY)N/A
PEG (5Y)2.74
Graham Number36.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROCE | 8.75% | ||
| ROIC | 6.25% | ||
| ROICexc | 6.42% | ||
| ROICexgc | 45.17% | ||
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% | ||
| FCFM | 6.08% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexgc growth 3Y30.99%
ROICexgc growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Debt/EBITDA | 3.47 | ||
| Cap/Depr | 96.19% | ||
| Cap/Sales | 3.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.74% | ||
| Profit Quality | 64.85% | ||
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 | ||
| Altman-Z | 2.22 |
F-Score5
WACC7.44%
ROIC/WACC0.84
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.7%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-26.26%
EPS Next Y-14.28%
EPS Next 2Y-3.35%
EPS Next 3Y0.55%
EPS Next 5Y3.92%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
Revenue Next Year4.92%
Revenue Next 2Y4.48%
Revenue Next 3Y4.2%
Revenue Next 5Y3.83%
EBIT growth 1Y-29.74%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year6.8%
EBIT Next 3Y6.69%
EBIT Next 5Y7.99%
FCF growth 1Y-34.14%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y-21.27%
OCF growth 3Y5.84%
OCF growth 5Y4.37%
MONDELEZ INTERNATIONAL INC-A / MDLZ FAQ
Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a fundamental rating of 5 / 10 to MDLZ.
What is the valuation status for MDLZ stock?
ChartMill assigns a valuation rating of 4 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Fairly Valued.
What is the profitability of MDLZ stock?
MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 7 / 10.
What are the PE and PB ratios of MONDELEZ INTERNATIONAL INC-A (MDLZ) stock?
The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 18.96 and the Price/Book (PB) ratio is 2.66.
How financially healthy is MONDELEZ INTERNATIONAL INC-A?
The financial health rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 3 / 10.